These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8136024)

  • 1. Contribution of the B16 and B26 tyrosine residues to the biological activity of insulin.
    Hu SQ; Burke GT; Katsoyannis PG
    J Protein Chem; 1993 Dec; 12(6):741-7. PubMed ID: 8136024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steric requirements at position B12 for high biological activity in insulin.
    Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
    Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
    Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
    Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution 1H-NMR studies of Des-(B26-B30)-insulin; assignment of resonances and properties of aromatic residues.
    Hua QX; Chen YJ; Wang CC; Wang DC; Roberts GC
    Biochim Biophys Acta; 1989 Feb; 994(2):114-20. PubMed ID: 2642711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending Halogen-based Medicinal Chemistry to Proteins: IODO-INSULIN AS A CASE STUDY.
    El Hage K; Pandyarajan V; Phillips NB; Smith BJ; Menting JG; Whittaker J; Lawrence MC; Meuwly M; Weiss MA
    J Biol Chem; 2016 Dec; 291(53):27023-27041. PubMed ID: 27875310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.
    Cosmatos A; Ferderigos N; Katsoyannis PG
    Int J Pept Protein Res; 1979; 14(5):457-71. PubMed ID: 395118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin analogues with modifications in the beta-turn of the B-chain.
    Wang SH; Hu SQ; Burke GT; Katsoyannis PG
    J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC; Zong L; Burke GT; Katsoyannis PG
    J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-assisted semisynthesis of shortened B26-modified insulins.
    Sievert D; Gattner HG; Lenz V; Höcker H
    Biomed Biochim Acta; 1991; 50(10-11):S197-200. PubMed ID: 1820045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superactive insulins.
    Burke GT; Hu SQ; Ohta N; Schwartz GP; Zong L; Katsoyannis PG
    Biochem Biophys Res Commun; 1990 Dec; 173(3):982-7. PubMed ID: 2268358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor.
    Slieker LJ; Brooke GS; DiMarchi RD; Flora DB; Green LK; Hoffmann JA; Long HB; Fan L; Shields JE; Sundell KL; Surface PL; Chance RE
    Diabetologia; 1997 Jul; 40 Suppl 2():S54-61. PubMed ID: 9248702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH; Tager HS
    J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shortened insulin with full in vitro potency.
    Fischer WH; Saunders D; Brandenburg D; Wollmer A; Zahn H
    Biol Chem Hoppe Seyler; 1985 May; 366(5):521-5. PubMed ID: 3890892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
    Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
    Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
    Mirmira RG; Tager HS
    Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies.
    Diaz JL; Wilkin TJ
    Clin Chem; 1988 Feb; 34(2):356-9. PubMed ID: 2449302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.